The Artificial Intelligence enabled Operating System for Biotechnology.
Reduce cost and time to market.
Our AI-enabled Enterprise Platform radically accelerates product development of therapeutics, high value chemicals, and agricultural products.
Let us help you make life better.
Leave your details and we'll get back to you shortly.
FEATURED IN
Shorten your time to market
From food to pharmaceuticals, from fuels to fabrics, shorten your time to market by harnessing the full power of artificial intelligence.
Start-to-Finish Solution
A single platform for design, construction, data gathering and analysis
Smooth Compatibility
Modular architecture offers multiple 3rd party integration points
Collaborative
Development
Empower scientists to collaborate across different projects
Secure and Scalable
Compliant with ISO 27001 on network security, data encryption, and availability
DESIGN
Design high throughput, high content experiments naturally suited to machine learning and bring them to fruition fast using our easy to use but powerful design tools and software for biotechnology suite.
BUILD
Bring your ideas to life. You shouldn’t be spending time adapting to your product development workflow, let us adapt it to you. Easily automate, manage and track what’s happening. Check this case study where we helped Arzeda™ integrate with Twist™ and LabCyte™
TEST
A clean, well lighted place for data. Acquire data from all your sources and bring it together, transformed and ready for analysis.
No need to worry about different formats and units. TeselaGen’s easy to use parsing and reformatting makes standardizing data fast and scalable.
EVOLVE
TeselaGen is powered by the Synthetic Evolution® machine learning engine.
Our proprietary artificial intelligence platform understands your data and helps you converge 10x faster.
Are you an academic group? A startup? An enterprise?
Don’t worry, we have something for everyone. Schedule a demo today.
Impact that you can measure.
7-fold
increase in
design & build speed
10-fold
reduction in
development costs
2-fold
increase in
production rate & titer
